The enzymology of tirapazamine (TPZ, SR 4233, WIN 59075, 3-amino-1,2,4-benz
otriazene 1,4-dioxide, Tirazone(TM)) has been extensively studied in rodent
s and to a lesser extent in human systems. While it is clear that the initi
al reductive step in TPZ activation is enzyme-mediated, there is limited co
nsensus in the published literature as to the relative contributions of the
cellular reductases involved. Moreover, not only is the importance of subc
ellullar localization for these putative activating reductase(s)far from cl
ear but their activity profiles in vivo are poorly defined. The same might
also be said of the potential detoxifying enzymes This review will attempt
to establish what common ground exists regarding the enzymology of TPZ meta
bolism, and will relate the available evidence to the enzyme profiles found
in human cell lines in vitro, as well as in xenograft models and human sol
id tumours.